Three amino acids can still carry biological information. KPV — lysine-proline-valine — is the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone, or α-MSH.
The melanocortin system participates in processes extending beyond pigmentation, including appetite, immune signalling and inflammation. Research into KPV has focused particularly on whether this small fragment can preserve some of α-MSH's anti-inflammatory properties.
Experimental studies in cell and animal models suggest that it can influence inflammatory signalling. Research has reported transport of KPV into intestinal epithelial and immune cells through the peptide transporter PepT1. In these experimental systems, investigators have reported effects involving NF-κB and MAP-kinase signalling, inflammatory cytokines, and mouse models of intestinal inflammation and colitis-associated cancer.
These findings are mechanistically interesting because they demonstrate how fragments derived from larger signalling molecules can retain distinct biological activity. They do not establish KPV as a proven treatment for inflammatory disease in humans.
Most of the evidence supporting these effects remains cellular or animal-based. Human efficacy and long-term safety require substantially more investigation before any therapeutic claim would be warranted.
KPV therefore represents a clear example of the difference between a compelling biological mechanism and a clinically validated intervention.
Research Status
Predominantly preclinical. PepT1-mediated transport and anti-inflammatory signalling are demonstrated in intestinal epithelial, immune and murine colitis models; no human efficacy data are established.
Selected Research
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology, 2008.
DOI: 10.1053/j.gastro.2007.10.026 · PMID: 18061177
- Viennois E, Ingersoll SA, Ayyadurai S, et al.. Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-Inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model. Cellular and Molecular Gastroenterology and Hepatology, 2016.
DOI: 10.1016/j.jcmgh.2016.01.006 · PMID: 27458604
Related Research